House Bill 2212
115th Congress(2017-2018)
CREATES Act of 2017
Introduced
Introduced in House on Apr 27, 2017
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2212
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Tom Marino
grade
Pennsylvania
District of Columbia
Florida
Illinois
Illinois
Indiana
Kentucky
Maryland
Mississippi
New Hampshire
New York
North Carolina
Ohio
Ohio
Ohio
Oregon
Rhode Island
Tennessee
Tennessee
Texas
Texas
Texas
Vermont
Virginia
Wisconsin
Wisconsin
No House votes have been held for this bill.
Summary
Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017
This bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved drug or biological product if the holder has declined to make available sufficient quantities of the approved drug or product for the developer's testing.
April 27, 2017
04/28/2017
Referred to the Subcommittee on Health.
04/27/2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
04/27/2017
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:35:54 PM